Immunomodulation by Tetracyclines in the Critically Ill: An Emerging Treatment Option?
Journal
Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902
Informations de publication
Date de publication:
22 03 2022
22 03 2022
Historique:
entrez:
26
3
2022
pubmed:
27
3
2022
medline:
1
4
2022
Statut:
epublish
Résumé
This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2022. Other selected articles can be found online at https://www.biomedcentral.com/collections/annualupdate2022 . Further information about the Annual Update in Intensive Care and Emergency Medicine is available from https://link.springer.com/bookseries/8901 .
Identifiants
pubmed: 35337355
doi: 10.1186/s13054-022-03909-1
pii: 10.1186/s13054-022-03909-1
pmc: PMC8951664
doi:
Substances chimiques
Tetracyclines
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
74Informations de copyright
© 2022. Sauer et al.
Références
Exp Mol Pathol. 2012 Jun;92(3):287-95
pubmed: 22421441
Pulm Pharmacol Ther. 2007;20(6):669-75
pubmed: 17045828
Int Immunopharmacol. 2019 Jul;72:243-251
pubmed: 31003001
Cureus. 2020 Aug 11;12(8):e9658
pubmed: 32802622
Int J Clin Exp Pathol. 2014 Oct 15;7(11):7460-8
pubmed: 25550781
Nat Med. 2015 Jul;21(7):677-87
pubmed: 26121197
Nat Rev Dis Primers. 2019 Mar 14;5(1):18
pubmed: 30872586
Antimicrob Agents Chemother. 2006 Feb;50(2):739-43
pubmed: 16436734
Shock. 2005 Oct;24(4):348-56
pubmed: 16205320
Mediators Inflamm. 2014;2014:708608
pubmed: 25580060
Clin Dev Immunol. 2011;2011:370872
pubmed: 21461372
Eur J Immunol. 2010 Mar;40(3):620-3
pubmed: 20201015
Int J Clin Exp Med. 2014 Dec 15;7(12):4975-82
pubmed: 25663995
Thorax. 2017 Jan;72(1):1-3
pubmed: 27974631
Pharmacol Res. 2015 Sep;99:44-51
pubmed: 26008138
Ann Thorac Surg. 2010 Aug;90(2):419-26
pubmed: 20667323
Antimicrob Agents Chemother. 1997 Jan;41(1):117-21
pubmed: 8980766
Pharmacol Ther. 2020 Apr;208:107476
pubmed: 31931100
Digestion. 2009;80(2):65-73
pubmed: 19494493
Circulation. 1999 Jul 27;100(4):400-6
pubmed: 10421601
Shock. 2004 Nov;22(5):478-81
pubmed: 15489642
Am J Physiol Cell Physiol. 2010 Sep;299(3):C539-48
pubmed: 20592239
J Surg Res. 2003 May 15;111(2):185-95
pubmed: 12850461
FEBS Lett. 1997 Jun 30;410(2-3):259-64
pubmed: 9237641
Am J Physiol Lung Cell Mol Physiol. 2006 Oct;291(4):L580-7
pubmed: 16698855
Crit Care Med. 2005 Jul;33(7):1577-81
pubmed: 16003065
J Inflamm (Lond). 2012 Sep 03;9(1):31
pubmed: 22943365
Shock. 2012 Apr;37(4):424-32
pubmed: 22258231
J Infect Chemother. 2018 Jun;24(6):470-475
pubmed: 29615379
J Immunol. 1999 Sep 15;163(6):3459-67
pubmed: 10477618
Shock. 2003 Sep;20(3):280-5
pubmed: 12923502
Int Immunopharmacol. 2001 Sep;1(9-10):1765-76
pubmed: 11562068
J Infect Dis. 1998 Feb;177(2):489-92
pubmed: 9466545
Nat Rev Drug Discov. 2021 Jan;20(1):39-63
pubmed: 33077936
Lancet Respir Med. 2021 Sep;9(9):1010-1020
pubmed: 34329624
Am J Respir Crit Care Med. 2021 Jul 1;204(1):53-63
pubmed: 33760701
Biochem Biophys Rep. 2015 Nov 05;4:397-404
pubmed: 29124230
Am J Respir Crit Care Med. 2010 Jun 15;181(12):1294-309
pubmed: 20167850
Crit Care. 2020 Mar 24;24(1):102
pubmed: 32204722
Biochim Biophys Acta. 2012 Apr;1820(4):503-10
pubmed: 22306153
Shock. 2006 Dec;26(6):587-91
pubmed: 17117134
Int Immunopharmacol. 2014 Jan;18(1):27-34
pubmed: 24239744
J Extra Corpor Technol. 1999 Jun;31(2):67-75
pubmed: 10724645
J Surg Res. 2001 Aug;99(2):245-52
pubmed: 11469893
Immunity. 2021 Jan 12;54(1):53-67.e7
pubmed: 33058782
Inflammation. 2020 Jun;43(3):1035-1043
pubmed: 31955291
Recent Pat Antiinfect Drug Discov. 2015;10(1):51-8
pubmed: 25858261
Transl Res. 2013 Feb;161(2):99-109
pubmed: 23108365
Biomed Res Int. 2020 Jul 20;2020:5459209
pubmed: 32766308